|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$35,175
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-04
|
$311,617
|
$155,809
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
Z01 BC 010871
|
$383,517
|
$38,352
|
Merlino, Glenn
|
CCR (NCI)
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-04S1
|
$60,563
|
$606
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-04
|
$1,332,378
|
$13,324
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-21S1
|
$61,058
|
$2,442
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-21
|
$5,994,681
|
$239,787
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Ubiquitin-Proteolytic Control of HOXA9 in Leukemogenesis
|
5R01CA118085-03
|
$290,571
|
$72,643
|
ZHOU, PENGBO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
Z01 BC 011029
|
$131,521
|
$131,522
|
Hakim, Frances
|
CCR (NCI)
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-03
|
$138,333
|
$138,333
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Transplanted Stem Cells and Tumor Progression
|
5R01CA118235-03
|
$265,423
|
$265,423
|
WONG, MELISSA
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
Transplantation of G-CSF Stimulated Marrow vs Blood
|
5R01CA108752-03
|
$491,522
|
$491,522
|
Schultz, KIRK
|
UNIVERSITY OF BRITISH COLUMBIA
|
|
Transplant Models
|
Z01 BC 010957
|
$530,539
|
$530,540
|
Gress, Ronald
|
CCR (NCI)
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
5R03CA130725-02
|
$84,500
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-24
|
$683,939
|
$683,939
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-21
|
$1,944,619
|
$583,386
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapeutic immunosuppression, inflammation & skin cancer
|
5R01CA109204-04
|
$251,966
|
$62,992
|
OBERYSZYN, TATIANA
|
OHIO STATE UNIVERSITY
|
|
Therapeutic anti-angiogenesis and tumor microenvironment
|
5R01CA107002-04
|
$262,921
|
$262,921
|
LANE, TIMOTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
THE THERAPY OF AML
|
5P01CA055164-16
|
$2,374,635
|
$593,659
|
ANDREEFF, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
5R01CA071669-10
|
$366,750
|
$366,750
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
|
1K08CA131097-01
|
$120,606
|
$30,152
|
krupnick, Alexander
|
WASHINGTON UNIVERSITY
|
|
The role of myeloid suppressor cells in tumor-specific tolerance
|
5R01CA124996-02
|
$311,600
|
$102,828
|
BORRELLO, IVAN
|
JOHNS HOPKINS UNIVERSITY
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-30
|
$2,959,846
|
$2,959,846
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$942,078
|
$188,416
|
Fowler, Daniel
|
CCR (NCI)
|
|
Techniques for modeling complex longitidinal studies
|
5R01CA054706-14
|
$233,320
|
$116,660
|
Klein, John
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Targeting Cell Cycle Machinery For Cancer Therapy
|
5R01CA109820-05
|
$292,538
|
$58,508
|
Reddy, E
|
TEMPLE UNIVERSITY
|
|
T cell homing in intestinal graft-versus-host disease
|
5R01CA107096-04
|
$323,957
|
$323,957
|
van den Brink, Marcel
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
STEM CELLS AND HEPATOCARCINOGENESIS
|
5R01CA112481-04
|
$255,805
|
$63,951
|
SELL, STEWART
|
ORDWAY RESEARCH INSTITUTE, INC.
|
|
Stem cell manipulation via HOX gene regulation
|
5R01CA090833-07
|
$280,779
|
$140,390
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
|
Stanford University Cancer Center
|
3P30CA124435-02S1
|
$80,833
|
$8,083
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-02
|
$1,572,967
|
$157,297
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$1,159
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$2,472
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$927
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$765
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$40,057
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Significance of mutations in human NOTCH1 in T cell acute lymphoblastic leukemia
|
5K08CA120544-03
|
$133,272
|
$33,318
|
CHIANG, MARK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Separation of GVH and GVL in Mouse Models
|
5R01CA079989-09
|
$261,354
|
$261,354
|
Sykes, Megan
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Roswell Park Research Experience Program
|
5R25CA084473-08
|
$233,330
|
$46,666
|
MICHALEK, ARTHUR
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
7R01CA113969-04
|
$316,480
|
$158,240
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Restoring T Cell Responses to Therapeutic Tumor Vaccines
|
5R01CA105148-04
|
$318,780
|
$318,780
|
FUCHS, EPHRAIM
|
JOHNS HOPKINS UNIVERSITY
|
|
Research and Mentoring in Psychosocial Oncology
|
5K05CA108955-05
|
$146,072
|
$109,554
|
Redd, William
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
REGULATION OF ANTI-TUMOR IMMUNITY
|
3P01CA109094-02S1
|
$60,179
|
$15,045
|
PODACK, ECKHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
REGULATION OF ANTI-TUMOR IMMUNITY
|
5P01CA109094-02
|
$1,169,175
|
$292,294
|
PODACK, ECKHARD
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Regional Oncology Research Center
|
5P30CA006973-46
|
$7,420,697
|
$667,863
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Rebuilding Immunity for Survival
|
5U19CA100265-05
|
$2,757,436
|
$2,757,436
|
NADLER, LEE
|
DANA-FARBER CANCER INSTITUTE
|
|
Radiation Sensitivity, DNA Repair and Second Cancers
|
7R01CA102542-05
|
$290,475
|
$290,475
|
FRIEDMAN, DEBRA
|
VANDERBILT UNIVERSITY
|
|
Psychosocial Palliative and Community Research in Cancer
|
5T32CA009461-25
|
$311,596
|
$31,160
|
OSTROFF, JAMIE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Psychoeducation for BMT caregivers: Biobehavioral markers and outcome
|
1R01CA126971-01A1
|
$558,411
|
$558,411
|
Laudenslager, Mark
|
UNIVERSITY OF COLORADO DENVER
|
|
Proteasome inhibitor (PS-341) and adoptive immunotherapy
|
5R01CA102282-05
|
$253,662
|
$253,662
|
MURPHY, WILLIAM
|
UNIVERSITY OF NEVADA RENO
|
Total relevant funding to Bone Marrow Transplantation for this search: $55,539,605
|